Literature DB >> 8533206

Measurement of diurnal variations in urinary cystine saturation.

A Lindell1, T Denneberg, J O Jeppsson, H G Tiselius.   

Abstract

In an attempt to improve the diagnostic value of urine analysis in patients with homozygous cystinuria, we studied the diurnal variation in urine composition. A simplified estimate of the ion-activity product of cystine was used to increase the probability of identifying patients with a particular risk of stone formation. Eight 6-h urine samples were collected during two 24-h periods. The highest urinary excretion of cystine was recorded between 1200 and 1800 hours and the lowest between 0000 and 0600 hours, whereas the urinary cystine concentration was highest between 0000 and 0006 hours and lowest between 1200 and 1800 hours. The approximate ion-activity product of cystine had a maximal level between 0000 and 0600 hours but a minimal level between 0600 and 1200 hours. The differences between different periods were numerically more pronounced in terms of the ion-activity product of cystine than in terms of concentration. The peak concentrations of cystine in 6-h samples were about 90% higher than the corresponding concentrations in 24-h urine samples. It is concluded that the analysis of cystine in 6-h urine samples reveals transient episodes of cystine supersaturation that otherwise will remain undetected. Further studies are, however, needed to establish its usefulness in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533206     DOI: 10.1007/bf00393301

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  21 in total

1.  Studies on the treatment of cystinuria.

Authors:  C E DENT; B SENIOR
Journal:  Br J Urol       Date:  1955-12

2.  Membranous glomerulonephritis induced by 2-mercaptopropionylglycine (2-MPG).

Authors:  A Lindell; T Denneberg; S Eneström; C Fich; T Skogh
Journal:  Clin Nephrol       Date:  1990-09       Impact factor: 0.975

3.  A simple method for the determination of glomerular filtration rate.

Authors:  J Bröchner-Mortensen
Journal:  Scand J Clin Lab Invest       Date:  1972-11       Impact factor: 1.713

4.  Evaluation of 99m Tc-DTPA for the measurement of glomerular filtration rate.

Authors:  J F Klopper; W Hauser; H L Atkins; W C Eckelman; P Richards
Journal:  J Nucl Med       Date:  1972-01       Impact factor: 10.057

5.  Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine.

Authors:  C Y Pak; C Fuller; K Sakhaee; J E Zerwekh; B V Adams
Journal:  J Urol       Date:  1986-11       Impact factor: 7.450

6.  Pharmacokinetics of oral tiopronin.

Authors:  M S Carlsson; T Denneberg; B M Emanuelsson; B Kågedal; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Determination of urinary cystine for monitoring anticystinuric therapy.

Authors:  E T Backer; A van den Ende; W P Geus
Journal:  Clin Chim Acta       Date:  1987-06-15       Impact factor: 3.786

8.  Alternative treatment of cystinuria with alpha-merkaptopropionylglycine, Thiola.

Authors:  T Denneberg; J O Jeppsson; P Stenberg
Journal:  Proc Eur Dial Transplant Assoc       Date:  1983

9.  Clinical course and cystine stone formation during tiopronin treatment.

Authors:  A Lindell; T Denneberg; E Hellgren; J O Jeppsson; H G Tiselius
Journal:  Urol Res       Date:  1995

10.  The use of D-penicillamine in cystinuria: efficacy and untoward reactions.

Authors:  E C Halperin; S O Thier; L E Rosenberg
Journal:  Yale J Biol Med       Date:  1981 Nov-Dec
View more
  3 in total

Review 1.  [Alkaline citrates in urology. A status report].

Authors:  L Rinnab; R E Hautmann; M Straub
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

2.  Cystine crystal volume determination: a useful tool in the management of cystinuric patients.

Authors:  Michel Daudon; Fabrice Cohen-Solal; Frédéric Barbey; Marie-France Gagnadoux; Bertrand Knebelmann; Paul Jungers
Journal:  Urol Res       Date:  2003-05-14

Review 3.  Changing paradigms in diagnosis of inherited defects associated with urolithiasis.

Authors:  Danika Bannasch; Paula S Henthorn
Journal:  Vet Clin North Am Small Anim Pract       Date:  2009-01       Impact factor: 2.093

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.